Medicine & Life Sciences
Aberrant Crypt Foci
11%
Adenocarcinoma
20%
Adenoma
52%
Adenomatous Polyposis Coli
29%
Anti-Inflammatory Agents
21%
Aspirin
19%
Barrett Esophagus
18%
Biomarkers
34%
Blood Platelets
7%
Carcinogenesis
26%
Celecoxib
70%
Chemoprevention
100%
Clinical Trials
15%
Colon
9%
Colorectal Neoplasms
46%
Confidence Intervals
14%
Cyclooxygenase 2 Inhibitors
17%
Cyclooxygenase Inhibitors
7%
Drug Development
14%
Early Detection of Cancer
15%
Eflornithine
21%
Emergency Responders
10%
Esophageal Neoplasms
10%
Exercise
8%
Genes
10%
Genotype
8%
Hepatocellular Carcinoma
12%
Hereditary Nonpolyposis Colorectal Neoplasms
12%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8%
Incidence
9%
Mucous Membrane
8%
National Cancer Institute (U.S.)
24%
Neoplasms
74%
Non-Steroidal Anti-Inflammatory Agents
7%
Pharmaceutical Preparations
21%
Placebos
24%
Polyps
19%
Population
12%
Prostaglandin-Endoperoxide Synthases
12%
Randomized Controlled Trials
7%
Safety
9%
Selenomethionine
12%
Single Nucleotide Polymorphism
8%
Sulindac
16%
sulindac sulfone
12%
Technology
7%
Therapeutics
10%
Translational Medical Research
11%
Ursodeoxycholic Acid
7%
Uterine Cervical Neoplasms
10%